Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial) [Phase 3]
Phase 3 trial PReCedeNT comparing PRRT alone versus PRRT with chemotherapy for gastroenteropancreatic neuroendocrine tumors is currently rec…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors. [Phase 3]
This clinical trial update indicates a Phase 3 study of systemic targeted adaptive radiotherapy for neuroendocrine tumors, currently recruit…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab in combination with liver-directed therapy or peptide receptor radionuclide therapy for neur…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors [NA]
A Barbara Ann Karmanos Cancer Institute study aims to address social determinants of health among cancer survivors in Metro Detroit and is c…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: Ivonescimab in the Treatment of Multiple Advanced Tumors [Phase 2]
An update indicating Ivonescimab is being studied in a Phase 2 trial for multiple advanced tumors and is currently recruiting. The trial cov…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours [Phase 2]
Phase 2 clinical study evaluating cessation of somatostatin analogue therapy after PRRT in midgut, hindgut, and pancreatic neuroendocrine tu…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours [Phase 2]
Phase 2 clinical trial evaluating Lutetium-177 Octreotate Therapy for neuroendocrine tumors is currently recruiting. The study is sponsored …
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: 68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs) [NA]
A completed clinical trial evaluating Gallium-68 DOTATATE PET-CT for diagnosing neuroendocrine tumors (NETs).
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases [Phase 2]
Phase 2 trial evaluating intra-arterial hepatic infusion of radiolabeled somatostatin analogs in patients with gastroenteropancreatic neuroe…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent [EARLY_Phase 1]
This Clinical Trial Update reports a first-in-human Phase 1 trial of an alpha-radiation imaging agent for neuroendocrine tumors (Grade 1 and…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors [EARLY_Phase 1]
An early Phase 1 clinical trial evaluating a dual-targeting tracer TATE-RGD for imaging SSTR- and RGD-positive tumors. The study targets iod…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: DOTATOC PET/CT for Imaging NET Patients
ClinicalTrials.gov entry describes a DOTATOC PET/CT imaging study for neuroendocrine tumors, sponsored by the British Columbia Cancer Agency…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Evaluation of the Quality of Life and Tolerance of Patients Treated With Vectorized Internal Radiotherapy (RIV) for a Neuro Endocrine Tumor (NET) in the Auvergne-Rhône-Alpes Region.
The clinical trial is currently recruiting to evaluate quality of life and tolerance of vectorized internal radiotherapy (RIV) in patients w…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies [NA]
Clinical trial update for 177Lu-CTR-FAPI in advanced metastatic digestive cancers; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors [Phase 1]
Phase 1 clinical trial update exploring the combination of PARP inhibitors with peptide receptor radionuclide therapy for neuroendocrine tum…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: 61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET) [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating the PET imaging agent 61Cu-NODAGA-LM3 for detecting neuroendocrine tumors; recruitment is currently…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Life Following Excision of Neuroendocrine Tumors
An update on a clinical trial studying outcomes after surgical excision of neuroendocrine tumors; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: 68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors [Phase 2]
A Phase 2 clinical trial is evaluating 68Ga-HA-DOTATATE PET imaging for suspected somatostatin receptor–positive neuroendocrine tumors.
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver [EARLY_Phase 1]
This clinical trial update describes an early-phase study of Lutathera in people with gastroenteropancreatic, bronchial, or unknown primary …
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: 18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
A clinical trial evaluating an 18F-labeled FAP-targeted molecular imaging probe for early tumor diagnosis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)
This clinical trial update describes the REBORN study, which aims to identify biomarkers for diagnosing neuroendocrine tumors and assessing …
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/Phase 2 study comparing radiopharmaceutical tracers Al18F-NOTA-LM3, 68Ga-DOTATATE, and 68Ga-N…
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
A multicenter Australia-New Zealand trial evaluating endoscopic tissue resection for upper gastrointestinal cancers; currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC (NESSIE) [Phase 2]
A Phase 2 clinical trial is evaluating a triple combination of sintilimab, IBI310, and surufatinib for high-grade neuroendocrine tumors and …
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial [Phase 2, Phase 3]
A clinical trial update for the ATSA trial evaluating absorbed tumor dose in peptide receptor radionuclide therapy using long-acting somatos…